Stock listing
Alamar Biosciences, Inc.
Selected listing: ALMR · NASDAQ · USD · US
Alamar Biosciences, Inc. (NASDAQ:ALMR), Health Technology. Latest release Oct 5, 2026: Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board…
- Ticker
- NASDAQ:ALMR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Alamar Biosciences, Inc.
The company focuses on innovative bioscience solutions, contributing to advancements in the healthcare sector. Alamar is committed to developing technologies that enhance patient outcomes and streamline medical processes.
Latest news from Alamar Biosciences, Inc.
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
October 5, 2026
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
September 24, 2026
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
August 10, 2026
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
July 28, 2026
Research Alamar Biosciences, Inc.
Alamar Biosciences, Inc. company profile
View the public company page for Alamar Biosciences, Inc. on 6ix.
Alamar Biosciences, Inc. news
Read company news and market updates connected to Alamar Biosciences, Inc..
Alamar Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Alamar Biosciences, Inc..